02:06 GMT14 August 2020
Listen Live
    Get short URL

    TORONTO (Sputnik) - Ottawa is working with Beijing to facilitate the start of testing of a Chinese vaccine candidate against the novel coronavirus disease in Canada, Prime Minister Justin Trudeau said during a briefing.

    Chinese biotechnology firm, CanSino Biologics Inc. (CanSinoBIO), received Canadian regulatory approval to begin testing in Canada in May but the process has been reportedly delayed by China’s customs authorities.

    “We’re obviously continuing to work with the Chinese government to ensure that this work can continue in an uninterrupted fashion,” Trudeau said on Thursday.

    There are also reports that Russia is among the countries being considered for CanSinoBIO’s COVID-19 vaccine phase III testing.

    The Ad5-nCoV candidate was developed in a joint venture by CanSinoBIO and the Chinese military’s Academy of Military Medical Sciences.

    Canadian Prime Minister Justin Trudeau has repeatedly stressed the daily constraints that much of the population is adhering to will be the new normal until a vaccine is developed.


    Man Invades Trudeau Residence with Restricted Rifle, Charged with Threatening to Kill Canada's PM
    Police Arrest Armed Man Near Trudeau's Residence, Prime Minister Was Not Home
    Man Who Broke Into Estate of Canadian PM Justin Trudeau Carried Multiple Weapons, Police Say
    Trudeau Warns US Against Imposing Unjustified Tariffs on Canadian Metals
    US, Canadian Media Vigorously Analyze Why Trudeau Skipped Trade Deal Summit With Trump
    Justin Trudeau, coronavirus, COVID-19, vaccine, China, Canada
    Community standardsDiscussion